Coronavirus: United States authorizes use of remdesivir for dealing with Covid-19 in spite of WHO questions

on
featured image

Remdesivir, developed by Gilead Sciences, has been approved for use in the treatment of Covid-19 patients. Photo: EPA-EFERemdesivir, developed by Gilead Sciences, has been approved for use in the treatment of Covid-19 patients. Photo: EPA-EFE

Remdesivir, developed by Gilead Sciences, has actually been authorized for usage in the treatment of Covid-19 clients. Picture: EPA-EFE

  • Drug, sold under the brand name Veklury, authorized for health center use in grownups and kids aged 12 and above
  • WHO’s Solidarity trial, covering 30 countries, found the drug had little impact on mortality, lowering the length of healthcare facility stays or require for a ventilator

Topic |.
Coronavirus pandemic

Zhuang Pinghui

Upgraded: 8: 06 pm, 23 Oct, 2020

Learn More

https://covid19globalcases.com/coronavirus-united-states-authorizes-use-of-remdesivir-for-dealing-with-covid-19-in-spite-of-who-questions/

Comments

Post a Comment